Delivery Order SPE2DB20D2014-SPE2DB24FB42C
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, a delivery order contract valued at $8,426.88, is for the procurement of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a period of performance through March 15, 2024 and is structured as a firm fixed price...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The $7,339.60 firm fixed price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a specialty pharmaceutical product. The award has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the product to the DLA Troop Support Medical facilities supporting the...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of the pharmaceutical product TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract, valued at $5,617.92, is a delivery order with a firm fixed price under the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract has a period of performance extending to July 16, 2024. This award is not associated with a set-aside designation. Amerisourcebergen, a major...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $1,726.60 delivery order contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Firm Fixed Price Delivery Order valued at $20,450.69. The contract is for the supply of 4565440388 TYPHIM VI 25 MCG/0.5 ML syringes to the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer. This award falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- The federal government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML in support of the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $81,663.67 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not set aside. In addition,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4563963247 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The award has a ceiling value of $12,516.28 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded...
- This federal contract award, valued at $5,452.82, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price structure and an ultimate completion date of August 20, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,872.64 to provide TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is responsible for delivering the pharmaceutical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB42CDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order worth $9,792.53 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which has an ultimate completion date of March 26, 2024. The award is not associated with a set-aside program. Additionally, Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 3/25/24 |